PRESS RELEASE Stockholm, September 26, 2005 Elekta's leading-edge radiation oncology and neurosurgical products have been selected by Providence Health System, which operates 18 acute care facilities in four US states. The health system has signed an exclusive, five-year provider contract with Elekta, initially covering 13-15 linear accelerator systems.

“Providence used several selection criteria in choosing the Elekta products,” according to David Hunter, System Director of Supply Chain Management at Providence. “Among them reliability, scope of products, service and reputation, and value-added enhancements. Elekta listened to our needs and demonstrated a commitment. We are pleased to offer our communities the most technologically advanced neurosurgery and radiation oncology solutions that are both effective and gentle to the patient.”

Elekta’s unique experience in image guidance and stereotactic applications in radiation treatment reaches back more than 30 years. On the basis of this experience and recent innovation, Elekta leads the development of new, advanced methods for ultra-precise radiation treatments.

“We are thrilled that a health system of Providence’s standing has awarded Elekta an exclusive contract for these vital systems,” said Anthony De Carolis, CEO of Elekta, Inc. and head of Elekta operations in North America. “After their experience with other manufacturers, Providence has decided Elekta can meet both the clinical and business requirements of their quality-focused health delivery facilities.”

Elekta’s radiation oncology and stereotactic radiosurgery solutions are readily available to 80 percent of acute care hospitals that report providing radiation therapy, thanks to contracts with several of the nation’s largest healthcare group purchasing organizations (GPOs).